Gulf International Bank UK Ltd Cuts Position in HCA Healthcare, Inc. (NYSE:HCA)

Gulf International Bank UK Ltd decreased its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 30.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,259 shares of the company’s stock after selling 4,866 shares during the quarter. Gulf International Bank UK Ltd’s holdings in HCA Healthcare were worth $3,890,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare during the first quarter worth $26,000. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare during the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC increased its position in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock worth $31,000 after acquiring an additional 80 shares during the period. ORG Partners LLC increased its holdings in HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after buying an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. increased its holdings in HCA Healthcare by 75.8% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock valued at $40,000 after buying an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $390.34 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market capitalization of $91.34 billion, a price-to-earnings ratio of 16.41, a price-to-earnings-growth ratio of 1.23 and a beta of 1.39. The firm has a 50-day simple moving average of $370.06 and a 200-day simple moving average of $350.57. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.50 earnings per share. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on HCA. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Truist Financial increased their target price on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. Barclays decreased their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating for the company in a research note on Monday, July 28th. Finally, JPMorgan Chase & Co. upped their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Nine investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $395.69.

View Our Latest Stock Analysis on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.